Effect of Atorvastatin on myocardial fibrosis, bone mass and muscle strength in elderly patients with heart failure complicated with low bone mass
DENG Liwen SANG Gengsheng▲
Department of Cardiovascular Medicine, the Third People’s Hospital of Bengbu Affiliated to Bengbu Medical College, Anhui Province, Bengbu 233000, China
Abstract Objective To investigate the effect of Atorvastatin on myocardial fibrosis, bone mass and muscle strength in elderly patients with heart failure complicated with low bone mass. Methods A total of 100 elderly patients with heart failure complicated with low bone mass who were admitted to the Third People’s Hospital of Bengbu Affiliated to Bengbu Medical College from September 2019 to June 2020 were selected as the research subjects, and they were divided into group A and group B according to random number table method, with 50 patients in each group. Group A was treated with conventional treatment, and group B was treated with Atorvastatin on the basis of group A. Both groups were treated for three months. The changes of myocardial fibrosis, bone mass and muscle strength before and after treatment were compared between the two groups, and the incidence of adverse reactions between the two groups was counted. Results There were no significant differences in the levels of type Ⅰ procollagen (PC Ⅰ), type Ⅲ procollagen (PC Ⅲ), laminin (LN) and hyaluronic acid (HA) between the two groups before treatment (P ＞ 0.05). After treatment, the levels of PC Ⅰ, PC Ⅲ, LN and HA in both groups were lower than those before treatment, and group B was lower than group A, the differences were statistically significant (all P ＜ 0.05). The changes of bone mineral density of lumbar anterior position L1-4, femoral neck and hip in group B were higher than those in group A, and the differences were statistically significant (all P ＜ 0.05). There were no significant differences in the change of left and right hand grip strength and the total incidence of adverse reactions between the two groups (P ＞ 0.05). Conclusion Atorvastatin treatment for elderly patients with heart failure complicated with low bone mass can effectively inhibit myocardial fibrosis and promote bone formation, but it has no obvious effect on muscle strength and has good safety.
DENG Liwen SANG Gengsheng▲. Effect of Atorvastatin on myocardial fibrosis, bone mass and muscle strength in elderly patients with heart failure complicated with low bone mass[J]. 中国医药导报, 2021, 18(11): 54-57.
